Screener
Guardant Health GH Business Segments — Research and development expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept gh:ResearchAndDevelopmentExpenseAdjusted.
The source filing: Guardant Health’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001576280-26-000026
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $301,665 | $203,471 |
| Less: | ||
| Cost of revenue (1) | 101,560 | 72,185 |
| Research and development expense (1) | 76,589 | 74,897 |
| Sales and marketing expense (1) | 154,430 | 94,127 |
| General and administrative expense (1) | 37,037 | 30,559 |
| Other segment items (2) | 44,124 | 26,862 |
| Net loss | $(112,075) | $(95,159) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Guardant Health's business segments — research and development expense?
- Guardant Health (GH) reported business segments — research and development expense of $76.59M in Q1 2026.
- How has Guardant Health's business segments — research and development expense changed year-over-year?
- Guardant Health's business segments — research and development expense increased by 2.3% year-over-year, from $74.9M to $76.59M.
- What is the long-term trend for Guardant Health's business segments — research and development expense?
- Over 3 years (2022 to 2025), Guardant Health's business segments — research and development expense has grown at a -3.3% compound annual growth rate (CAGR), from $341.65M to $309.18M.
- What does business segments — research and development expense mean?
- These are the costs incurred to discover, develop, and improve the company's diagnostic technologies and clinical test pipelines. This investment is critical for long-term innovation and maintaining a competitive edge in the oncology testing market.
Ask your AI about Guardant Health's business segments — research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude